// App-Quantinova.ai

: R-DA-EPOCH Treatment Is Highly Effective Therapy for Primary Mediastinal Large B-Cell Lymphoma: A Real-World Multi-Centre Retrospective Evaluation

Researchers

Presenter

  • Anna Santarsieri

Principal Investigators

  • Rory Bennett

  • David Hopkins

  • Katharine L. Lewis

  • Cecilia N Gyansah

  • Lisa Cooke

  • Sateesh K. Nagumantry

  • Nimish K. Shah

  • Chan Y. Cheah

  • Pamela McKay

  • Michael Dickinson

  • John F. Seymour

  • George A Follows

Medical Centers

  • Sir Charles Gairdner Hospital, University of Western Australia, Perth, Australia

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Peterborough City Hospital, Peterborough, United Kingdom

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, Australia

  • Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, United Kingdom

  • Peter MacCallum Cancer Centre, MELBOURNE, Australia

  • The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, United Kingdom

Locations

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Non-Hodgkin's Lymphoma

  • Mediastinal mass

  • B cell lymphomas

  • Non‐Hodgkin Lymphoma

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Lactate dehydrogenase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved